Cohen Klingenstein Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$205K |
| 3 |
APOL
Apollo Education Group Inc Class A
APOL
|
+$202K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.83M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$650K |
| 3 |
Walt Disney
DIS
|
+$472K |
| 4 |
Gilead Sciences
GILD
|
+$405K |
| 5 |
Nu Skin
NUS
|
+$308K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 10.59% |
| 2 | Healthcare | 8.37% |
| 3 | Financials | 8.05% |
| 4 | Technology | 7.4% |
| 5 | Consumer Staples | 6.56% |
Similar funds
Cohen Klingenstein's Q4 2014 Portfolio in Review
As of Q4 2014, Cohen Klingenstein held 160 positions worth $533M, down 6% from $567M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Cohen Klingenstein withdrew a net $53.3M in Q4 2014, closing 4 positions and reducing 27 holdings. Its most notable exit was Nu Skin, an estimated $308K position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 11% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Cohen Klingenstein opened a new position in State Street SPDR S&P MIDCAP 400 ETF Trust worth $211K.
- Cohen Klingenstein's largest Q4 2014 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 800 shares worth $211K.
- Cohen Klingenstein added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.24M increase.
- Cohen Klingenstein's biggest Q4 2014 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $1.83M.
- Cohen Klingenstein fully exited Nu Skin in Q4 2014, selling an estimated $308K.
- Cohen Klingenstein's ten largest holdings make up 53% of its $533M portfolio in Q4 2014.
- Cohen Klingenstein opened 2 new positions and closed 4 in Q4 2014.
- Cohen Klingenstein's portfolio value fell 6% quarter-over-quarter to $533M.
Based on Cohen Klingenstein's 13F filing for Q4 2014, filed 13 Jan 2015.